AP
MD icon

AHL Partners’s Pediatrix Medical MD Stock Holding History

AHL Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$7M Buy
130,928
+24,381
+23% +$1.15M 0.11% 359
2017
Q3 		$4.59M Sell
106,547
-84,114
-44% -$4M 0.08% 423
2017
Q2 		$11.5M Buy
190,661
+63,228
+50% +$3.75M 0.25% 70
2017
Q1 		$8.84M Buy
127,433
+114,318
+872% +$7.94M 0.2% 147
2016
Q4 		$874K Sell
13,115
-34,461
-72% -$2.24M 0.03% 693
2016
Q3 		$3.15M Sell
47,576
-9,192
-16% -$629K 0.12% 263
2016
Q2 		$4.11M Buy
56,768
+47,073
+486% +$3.24M 0.22% 102
2016
Q1 		$627K Sell
9,695
-51,456
-84% -$3.41M 0.04% 520
2015
Q4 		$4.38M Buy
61,151
+36,520
+148% +$2.7M 0.34% 91
2015
Q3 		$1.89M Sell
24,631
-99,431
-80% -$8.02M 0.3% 75
2015
Q2 		$9.19M Buy
124,062
+19,722
+19% +$1.42M 0.37% 17
2015
Q1 		$7.57M Buy
104,340
+29,426
+39% +$2.05M 0.3% 21
2014
Q4 		$4.95M Sell
74,914
-24,962
-25% -$1.52M 0.26% 62
2014
Q3 		$5.47M Buy
+99,876
New +$5.67M 0.42% 32

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

AHL Partners's MD Position: Q4 2017 in Review

AHL Partners increased its Pediatrix Medical (MD) stake by 23% in Q4 2017, buying an estimated $1.15M and bringing the position to 130,928 shares worth $7M. The position accounts for 0.11% of the portfolio, ranked #359.

AHL Partners first reported a position in MD in Q3 2014 and has held it in 14 quarters since. The position peaked at $11.5M in Q2 2017. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • AHL Partners held 130,928 shares of Pediatrix Medical worth $7M as of Q4 2017.
  • AHL Partners bought 24,381 Pediatrix Medical shares in Q4 2017, an estimated $1.15M.
  • Pediatrix Medical made up 0.11% of AHL Partners's portfolio in Q4 2017, its #359 holding.
  • AHL Partners first reported a position in Pediatrix Medical in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Pediatrix Medical position peaked at $11.5M in Q2 2017.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.